Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Xiang-sha-liu-jun Granules as an Herbal Formula for the Treatment of Postprandial Distress Syndrome(PDS): a Prospective, Double-blinded, Randomized and Placebo-controlled,Three-center Trial

NCT02762136 is registered in ClinicalTrials.gov with Xiyuan Hospital of China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT02762136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02762136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Xiang-sha-liu-jun Granules as an Herbal Formula for the Treatment of Postprandial Distress Syndrome(PDS): a Prospective, Double-blinded, Randomized and Placebo-controlled,Three-center Trial
Lead sponsor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 31, 2015
Completion date
April 30, 2018
Enrollment
216 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

postprandial distress syndrome